LGALS1 and type 2 diabetes mellitus: Using the large, population-based Malmö Diet and Cancer Study–Cardiovascular Cohort (MDCS-CC), we aimed to examine whether circulating galectin-1 levels associate with incident CKD and type 2 diabetes, independently of established risk factors.